The rapid proliferation of peptide therapies in recent years has outpaced the traditional clinical trial process
QUICK SPECS Form: Lyophilized powder Net per vial: 10 mg Purity: 98% (HPLC) Identity: MS-verified (per COA) Storage: -20C, protect from light
While BPC-157 provides fast-acting benefits, it is important to follow a structured treatment plan to allow sufficient time for the bone to heal completely
Reduces chronic inflammation FOXO4-DRI reduces chronic inflammation by targeting and eliminating senescent cells, which are known to be major contributors to inflammation in the body
Tissue repair, recovery, and skin BPC-157 (Body Protection Compound) Studied for tissue repair, gut lining health, tendon and ligament recovery, and reduction of localized inflammation
Inflammatory back pain beginning before age 45 that responds to anti-inflammatory treatment warrants sacroiliac joint imaging and a rheumatology assessment